Griseofulvin (Qualitest Pharmaceuticals)
Welcome to the PulseAid listing for the Griseofulvin drug offered from Qualitest Pharmaceuticals. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Qualitest Pharmaceuticals |
NON-PROPRIETARY NAME: | Griseofulvin |
SUBSTANCE NAME: | GRISEOFULVIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-10-08 |
END MARKETING DATE: | 2018-02-28 |
Griseofulvin HUMAN PRESCRIPTION DRUG Details:
Item Description | Griseofulvin from Qualitest Pharmaceuticals |
LABELER NAME: | Qualitest Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/5mL) |
START MARKETING DATE: | 2010-10-08 |
END MARKETING DATE: | 2018-02-28 |
PRODUCT ID: | 0603-9171_edba0d01-d72e-48de-9528-9ddf9fd1a838 |
PRODUCT NDC: | 0603-9171 |
APPLICATION NUMBER: | ANDA065438 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers: